Your browser doesn't support javascript.
loading
MiR-126: a novel route for natalizumab action?
Meira, Maria; Sievers, Claudia; Hoffmann, Francine; Derfuss, Tobias; Kuhle, Jens; Kappos, Ludwig; Lindberg, Raija L P.
Afiliación
  • Meira M; University Hospital Basel, University of Basel, Switzerland.
  • Sievers C; University Hospital Basel, University of Basel, Switzerland.
  • Hoffmann F; University Hospital Basel, University of Basel, Switzerland.
  • Derfuss T; University Hospital Basel, University of Basel, Switzerland.
  • Kuhle J; University Hospital Basel, University of Basel, Switzerland.
  • Kappos L; University Hospital Basel, University of Basel, Switzerland.
  • Lindberg RL; University Hospital Basel, University of Basel, Switzerland Raija.lindberg@unibas.ch.
Mult Scler ; 20(10): 1363-70, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24598267

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / MicroARNs / Anticuerpos Monoclonales Humanizados / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / MicroARNs / Anticuerpos Monoclonales Humanizados / Inmunosupresores / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Suiza